CABALETTA BIO, INC. Increase (Decrease) in Prepaid Expense and Other Assets
CABALETTA BIO, INC. (CABA) reported Increase (Decrease) in Prepaid Expense and Other Assets of $658.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- CABALETTA BIO, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $249.00K, a 74.04% decline year-over-year.
- CABALETTA BIO, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $409.00K, a 671.70% increase year-over-year.
- CABALETTA BIO, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $642.00K, a 205.71% increase year-over-year.
- CABALETTA BIO, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $905.00K.
- CABALETTA BIO, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $2.56M.
- CABALETTA BIO, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$528.00K, a 155.35% decline from fiscal 2023.
- CABALETTA BIO, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $954.00K.
- CABALETTA BIO, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$32.00K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $249.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $658.00K 10-Q · filed 2026-08-13 | $1.30M derived: sum of 3 quarters · filed 2026-08-13 | $2.21M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $409.00K 10-Q · filed 2026-05-14 | $1.05M derived: sum of 2 quarters · filed 2026-05-14 | $1.96M derived: sum of 3 quarters · filed 2026-05-14 | $2.92M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $642.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $1.55M derived: sum of 2 quarters · filed 2026-03-23 | $2.51M derived: sum of 3 quarters · filed 2026-08-13 | $2.56M 10-K · filed 2026-03-23 |
| 2025-09-30 | $905.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.86M derived: sum of 2 quarters · filed 2026-08-13 | $1.92M 10-Q · filed 2025-11-10 | $2.13M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $959.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.01M 10-Q · filed 2026-08-13 | $1.22M derived: sum of 3 quarters · filed 2026-08-13 | $694.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $53.00K 10-Q · filed 2026-05-14 | $263.00K derived: sum of 2 quarters · filed 2026-05-14 | -$265.00K derived: sum of 3 quarters · filed 2026-05-14 | -$869.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $210.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$318.00K derived: sum of 2 quarters · filed 2026-03-23 | -$922.00K derived: sum of 3 quarters · filed 2026-03-23 | -$528.00K 10-K · filed 2026-03-23 |
| 2024-09-30 | -$528.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$1.13M derived: sum of 2 quarters · filed 2025-11-10 | -$738.00K 10-Q · filed 2025-11-10 | $716.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$604.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$210.00K 10-Q · filed 2025-08-07 | $1.24M derived: sum of 3 quarters · filed 2025-08-07 | $1.79M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $394.00K 10-Q · filed 2025-05-15 | $1.85M derived: sum of 2 quarters · filed 2025-05-15 | $2.39M derived: sum of 3 quarters · filed 2025-05-15 | $1.75M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $2.00M derived: sum of 2 quarters · filed 2025-03-31 | $1.35M derived: sum of 3 quarters · filed 2025-03-31 | $954.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $543.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$102.00K derived: sum of 2 quarters · filed 2024-11-14 | -$500.00K 10-Q · filed 2024-11-14 | -$493.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$645.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$1.04M 10-Q · filed 2024-08-08 | -$1.04M derived: sum of 3 quarters · filed 2024-08-08 | -$695.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$398.00K 10-Q · filed 2024-05-15 | -$391.00K derived: sum of 2 quarters · filed 2024-05-15 | -$50.00K derived: sum of 3 quarters · filed 2024-05-15 | -$337.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $348.00K derived: sum of 2 quarters · filed 2024-03-21 | $61.00K derived: sum of 3 quarters · filed 2024-03-21 | -$32.00K 10-K · filed 2024-03-21 |
| 2022-09-30 | $341.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $54.00K derived: sum of 2 quarters · filed 2023-11-09 | -$39.00K 10-Q · filed 2023-11-09 | $687.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$287.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$380.00K 10-Q · filed 2023-08-10 | $346.00K derived: sum of 3 quarters · filed 2023-08-10 | -$269.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$93.00K 10-Q · filed 2023-05-11 | $633.00K derived: sum of 2 quarters · filed 2023-05-11 | $18.00K derived: sum of 3 quarters · filed 2023-05-11 | -$1.50M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $726.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $111.00K derived: sum of 2 quarters · filed 2023-03-16 | -$1.41M derived: sum of 3 quarters · filed 2023-03-16 | -$2.55M 10-K · filed 2023-03-16 |
| 2021-09-30 | -$615.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$2.13M derived: sum of 2 quarters · filed 2022-11-10 | -$3.28M 10-Q · filed 2022-11-10 | -$885.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$2.67M 10-Q · filed 2022-08-11 | -$270.00K derived: sum of 3 quarters · filed 2022-08-11 | -$1.47M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$1.15M 10-Q · filed 2022-05-12 | $1.25M derived: sum of 2 quarters · filed 2022-05-12 | $51.00K derived: sum of 3 quarters · filed 2022-05-12 | $609.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $1.20M derived: sum of 2 quarters · filed 2022-03-17 | $1.75M derived: sum of 3 quarters · filed 2022-03-17 | $524.00K 10-K · filed 2022-03-17 |
| 2020-09-30 | -$1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | -$641.00K derived: sum of 2 quarters · filed 2021-11-01 | -$1.87M 10-Q · filed 2021-11-01 | $1.95M derived: sum of 4 quarters · filed 2021-11-01 |
| 2020-06-30 | $558.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$672.00K 10-Q · filed 2021-08-05 | $3.15M derived: sum of 3 quarters · filed 2021-08-05 | $2.79M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -$1.23M 10-Q · filed 2021-05-03 | $2.59M derived: sum of 2 quarters · filed 2021-05-03 | $2.23M derived: sum of 3 quarters · filed 2021-05-03 | $2.89M derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | $3.82M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $3.46M derived: sum of 2 quarters · filed 2021-03-16 | $4.12M derived: sum of 3 quarters · filed 2021-03-16 | $3.37M 10-K · filed 2021-03-16 |
| 2019-09-30 | -$356.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $300.00K derived: sum of 2 quarters · filed 2020-11-10 | -$449.00K 10-Q · filed 2020-11-10 | $308.00K derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $656.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$93.00K 10-Q · filed 2020-08-06 | $664.00K derived: sum of 3 quarters · filed 2020-08-06 | |
| 2019-03-31 | -$749.00K 10-Q · filed 2020-05-12 | $8.00K derived: sum of 2 quarters · filed 2020-05-12 | ||
| 2018-12-31 | $757.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $977.00K 10-K · filed 2020-03-30 | ||
| 2018-09-30 | $220.00K 10-Q · filed 2019-12-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |